413 results
8-K
EX-99.1
GILD
Gilead Sciences, Inc.
25 Apr 24
Gilead Sciences Announces First Quarter 2024 Financial Results
4:04pm
of its long-term ambitions or priorities laid out in its corporate strategy; Gilead’s ability to accelerate or sustain revenues for its virology … assets
Liabilities and Stockholders’ Equity
Current liabilities
Long-term liabilities
Stockholders’ equity(1)
Total liabilities and stockholders
SC TO-T
EX-99
kf8aw3mi6
23 Feb 24
Third party tender offer statement
6:09am
8-K
EX-99.1
sa8zu5 9f0
6 Feb 24
Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results
4:04pm
8-K
EX-99.1
j76uv2dqox3358
7 Nov 23
Gilead Sciences Announces Third Quarter 2023 Financial Results
4:03pm
424B5
dxiww2
11 Sep 23
Prospectus supplement for primary offering
4:09pm
424B5
c16a5ldaw68x z7dn3dv
7 Sep 23
Prospectus supplement for primary offering
8:29am
8-K
EX-99.1
tf963myq8z0qrc4lu78
3 Aug 23
Gilead Sciences Announces Second Quarter 2023 Financial Results
4:07pm
8-K
EX-99.1
curbwr4c
27 Apr 23
Gilead Sciences Announces First Quarter 2023 Financial Results
4:05pm
CORRESP
us4uv0yzdz2wles
25 Apr 23
Correspondence with SEC
12:00am
8-K
EX-99.1
gr4b v4b568j
27 Oct 22
Gilead Sciences Announces Third Quarter 2022 Financial Results
4:04pm